FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for NICORETTE (nicotine polacrilex), a nicotine replacement therapy, submitted by Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Smoking Cessation
• Tobacco Use Disorder

Drugs mentioned

• NICORETTE (Nicotine polacrilex)

Snippet

SUPPL AP for NICORETTE (NICOTINE POLACRILEX)